The Wall Street Journal reports on work from Anna Pomés and Martin Chapman, scientists who are looking into the DNA composition of allergens to better understand human immune response. "They are also working to create 'mutant' allergens that one day may be used to treat allergy sufferers with fewer side effects," the story says.
Mutant Allergens? We're Keeping Our Claritin Close
Oct 13, 2009